Cargando…

Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) is a rare and lethal form of thyroid cancer that requires urgent investigation of new molecular targets involved in its aggressive biology. In this context, the overactivation of Polycomb Repressive Complex 2/EZH2, which induces chromatin compaction, is frequently obs...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mello, Diego Claro, Saito, Kelly Cristina, Cristovão, Marcella Maringolo, Kimura, Edna Teruko, Fuziwara, Cesar Seigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178714/ https://www.ncbi.nlm.nih.gov/pubmed/37175580 http://dx.doi.org/10.3390/ijms24097872

Ejemplares similares

MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2014)

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2022)

Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2019)

How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2020)

Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer
por: de Santa-Inez, Daniel Casartelli, et al.
Publicado: (2021)

The Highly Expressed FAM83F Protein in Papillary Thyroid Cancer Exerts a Pro-Oncogenic Role in Thyroid Follicular Cells
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2019)

Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2015)

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
por: Miasaki, Fabíola Yukiko, et al.
Publicado: (2020)

MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells
por: Lima, Cilene Rebouças, et al.
Publicado: (2016)

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
por: Choi, Yoon Ju, et al.
Publicado: (2021)

hnRNP A1 and hnRNP C associate with miR‐17 and miR‐18 in thyroid cancer cells
por: dos Santos, Maria Gabriela Pereira, et al.
Publicado: (2022)

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
por: Larson, Steven M., et al.
Publicado: (2017)

Antiproliferation and Redifferentiation in Thyroid Cancer Cell Lines by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAF(V600E) Mutation by Bioinformatics Integrative Analysis
por: Goedert, Lucas, et al.
Publicado: (2017)

Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
por: Su, Xi, et al.
Publicado: (2020)

Study on the Antitumor Effect and Glycolysis of Andrographolide in Anaplastic Thyroid Carcinoma
por: Yang, Ke, et al.
Publicado: (2021)

Strategies to Modulate the Redifferentiation of Chondrocytes
por: Hu, Xiaoshen, et al.
Publicado: (2021)

Letter to the Editor: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals
por: Kim, Tae Yong
Publicado: (2011)

The Author Response: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Osteoglycin inhibition by microRNA miR-155 impairs myogenesis
por: Freire, Paula Paccielli, et al.
Publicado: (2017)

Fibroblast rejuvenation by mechanical reprogramming and redifferentiation
por: Roy, Bibhas, et al.
Publicado: (2020)

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
por: Aashiq, Mohamed, et al.
Publicado: (2019)

Redifferentiated Chondrocytes for the Repair of Articular Cartilage Lesions
por: Bianchi, Vanessa Juliana, et al.
Publicado: (2017)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
por: Jiang, Ke, et al.
Publicado: (2018)

Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells
por: Kawamura, Yoshifumi, et al.
Publicado: (2021)

New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
por: Wong, Kai-Pun, et al.
Publicado: (2012)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
por: Oh, Ji Min, et al.
Publicado: (2022)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer
por: Geraldo, Murilo Vieira, et al.
Publicado: (2016)

The Interplay between Chondrocyte Redifferentiation Pellet Size and Oxygen Concentration
por: Babur, Betul Kul, et al.
Publicado: (2013)

Redifferentiation of expanded human islet β cells by inhibition of ARX
por: Friedman-Mazursky, Orr, et al.
Publicado: (2016)

ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
por: Zhang, Peng, et al.
Publicado: (2023)

The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study
por: Haghpanah, Vahid, et al.
Publicado: (2014)

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
por: Cheng, Lingxiao, et al.
Publicado: (2017)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6dfvq1kvp7qk92271k4f04lgaq